tuberculosis vaccine

BIOLOGICAL2 trials

Sponsors

Research Institute for Biological Safety Problems, Bharat Biotech International Limited

Conditions

Tuberculosis

Phase 1

Reactogenicity, Safety and Immunogenicity of a TB/FLU-04L Tuberculosis Vaccine

CompletedNCT02501421

Research Institute for Biological Safety ProblemsTuberculosis

Start: 2013-10-31End: 2015-02-28Updated: 2020-08-28

Tuberculosis Vaccine in Healthy Indian Adults

CompletedNCT06438978

Bharat Biotech International LimitedTuberculosis

Start: 2024-01-19End: 2024-07-27Updated: 2025-05-22